Bronchiolitis obliterans organizing pneumonia: clinicopathologic review of a series of 45 Korean patients including rapidly progressive form. by Chang, Joon et al.
INTRODUCTION
Bronchiolitis obliterans organizing pneumonia (BOOP)
is a clinicopathologic syndrome first described in 1985 and
has become increasingly recognized in association with a vari-
ety of causes or conditions (1-9). It is histologically defined
by the presence of buds of granulation tissue consisting of
fibroblasts and collagen within the lumen of the distal air-
spaces. BOOP may be idiopathic or secondary being associ-
ated with various underlying conditions and most of cases of
BOOP reported in larger studies were idiopathic (also called
cryptogenic organizing pneumonia [COP]) (5, 6, 9). The dis-
ease is usually manifested as a distinct clinicopathological
syndrome of subacute pneumonia, with typical alveolar patchy
and often migratory pulmonary opacities on imaging. Other
imaging presentations consist of diffuse infiltrative opacities
or focal pneumonia (3, 10, 11). The clinical response to cor-
ticosteroids is usually dramatic, but relapses are common dur-
ing tapering after the discontinuation of the treatment (1-
9). There have been several case reports of BOOP with unfa-
vorable, even lethal outcome (12, 13) and recent collective
follow-up studies of similar cases described patients with unfa-
vorable outcome or rapidly progressive respiratory failure that
has been obviously attributed to BOOP (14, 15). However
rapidly progressive BOOP cases have not been reported in
Korea.
BOOP should not be considered as a specific histopatho-
logic feature, since the disease has been reported in a wide
variety of conditions, such as infection, connective-tissue
diseases, vasculitides, hypersensitivity pneumonitis (HP),
and chronic eosinophilic pneumonia (CEP) and can occur as
a secondary inflammatory process in idiopathic interstitial
pneumonia and organizing diffuse alveolar damage (DAD),
and is also commonly noted as a process secondary to local-
ized lesions (16, 17). Thus, before considering BOOP as the
primary cause of respiratory disease in a patient, possible un-
derlying disease entities should be carefully ruled out by both
clinicians and pathologists (1, 2, 18, 19). 
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Bronchiolitis Obliterans Organizing Pneumonia: Clinicopathologic
Review of a Series of 45 Korean Patients Including Rapidly 
Progressive form
Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathological
syndrome associated with a variety of disease entities. The aim of this study was
to review cases with initial diagnosis of BOOP applying uniform histopathologic
criteria, and analyze the clinical characteristics of proven cases of BOOP includ-
ing rapidly progressive form. A total of 81 cases, initially diagnosed as BOOP and
with available tissue sections, was collected. Thirty six cases (44.4%) were ex-
cluded from the study, more than two thirds of which were given a revised diag-
nosis of interstitial pneumonitis/fibrosis other than BOOP. Thirty one patients were
classified as idiopathic BOOP, 8 patients as secondary BOOP, and 6 patients
as rapidly progressive BOOP. Open lung biopsy specimen from all six cases with
lethal outcome showed more severe interstitial inflammation and septal fibrosis
and/or alveolar exudate with a varying degree than those with good prognosis.
There was no difference by the sexes. The two most frequent presenting symp-
toms were cough and dyspnea. Bilateral multifocal consolidation was a common
radiological finding. More than 70% cases of idiopathic BOOP experienced clini-
cal improvements. The diagnosis of BOOP is usually suggested by clinicoradio-
logic findings, but needs to be confirmed histopathologically, preferably through
surgical open or video-assisted thoracoscopic biopsy.
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We reviewed cases with initial diagnosis of BOOP apply-
ing uniform histopathologic criteria, and then analyzed the
clinical characteristics of proven cases of BOOP, including
rapidly progressive form.
MATERIALS AND METHODS
A total of 81 patients, initially diagnosed as BOOP and
with available tissue sections, were accrued from 19 major
general hospitals (including 17 university hospitals) in Korea.
In six cases, the submitted lung tissue was inadequate for
proper examination. The hematoxylin-eosin stained sections
in all cases were initially examined for the presence of intra-
luminal organization both in the alveolar ducts or alveoli
(organizing pneumonia) and bronchiolar lumina (bronchi-
olitis obliterans) by one of the authors (DHS) in a blinded
fashion and then the other pathologist (JH) independently
reviewed cases selected for consensus opinion based on the
generally accepted histologic features (16). Discrepancies
were resolved by re-review and mutual agreement. Some of
cases submitted had been discussed in the monthly meeting
of Korean Study Group of Cardiovascular and Pulmonary
Pathology. In some cases, slides with complementary stains
(Verhoeff, trichrome, PAS, acid fast, and methenamine silver)
were also reviewed. The biopsy specimens were obtained by
various methods, such as open lung/or thoracoscopic biopsy
(n=39), fiberoptic transbronchial lung biopsy (n=5), and core
needle biopsy (n=1) (Table 1). 
Given the fact that the presence of necrosis, acute inflam-
mation, microabscess formation, and vasculitis serves as strong
evidence against the diagnosis of BOOP (16), pathologic diag-
noses of interstitial pneumonia/fibrosis other than BOOP
were made in 16 cases and infectious bronchiolitis/pneumonia
in 4 cases. There were no bronchiolitis obliterans, however
microgranulomas in three cases suggested hypersensitivity
reaction or infection. Patchy organizing pneumonia suggest-
ing post-aspiration reaction or an association with space-occu-
pying lesion was recognized in seven cases. Thus 45 cases
were finally confirmed as histopathologically proven BOOP
(Table 2). 
Clinical data were collected retrospectively from the clini-
cal records with a standardized data sheet and were reviewed
by a single investigator (JC), who was unaware of pathologic
information. All patients enrolled in the study were required
to meet the following criteria: 1) radiologic lung infiltrates;
2) lung biopsy compatible with BOOP.
RESULTS
Pathologic review and patients characteristics
At low magnification, the most distinguishing histologic
features were the patchy nature of the lesion consisting of
small buds of fibromyxoid tissue in the small bronchiole, alve-
olar ducts, and alveoli (Fig. 1). The connective tissue buds
were more conspicuous in alveoli than in bronchiolar lumina
and extended from one alveolus to another. The buds con-
tained loosely woven fibers of collagen and reticulin, which
were highlighted by van Gieson’ s and Masson’ s trichrome
stains. The extent of involvement of various small conduct-
ing airways differed from case to case. Terminal bronchioles
Method of lung biopsy
Open lung or thoracoscopic 28 5 6
Fiberoptic transbronchial 2 3 0
Core needle 1 0 0
Age (mean± S.D., years) 50.6±11.4 33.8±17.3 50.5±16.5
Sex (male:female) 19:12 5:3 4:2
Current or former smoker 11/24 (46%) 2/6 (33.3%) 2/4 (50%)
Cough 25 (80.7%) 3 (37.5%) 1 (16.7%)
Dyspnea 20 (64.5%) 3 (37.5%) 6 (100.0%)
Sputum 15 (48.4%) 3 (37.5%) 0
Hemoptysis 1 (3.2%) 0 0
Pleuritic chest pain 5 (16.1%) 2 (25.0%) 0
Weight loss (>2 kg) 3 (9.7%) 1 (12.5%) 2 (33.3%)
Fever 6 (19.4%) 2 (25.0%) 2 (33.3%)
Night sweat 3 (9.7%) 0 0
Flu-like illness 5 (16.1%) 1 (12.5%) 0
Tachypnea 3 (9.7%) 2 (25.0%) 1 (16.7%)
Fine crackles 17 (54.8%) 3 (37.5%) 5 (83.3%)
Cyanosis 0 0 1 (16.7%)
Idiopathic
(n=31)
Secondary
(n=8)
Rapidly 
progressive
(n=6)
Table 1. Method of lung biopsy and patient characteristics  
Bronchiolitis obliterans organizing pneumonia (BOOP) 45
Idiopathic BOOP (not rapidly progressive) 31
Secondary BOOP (with known cause or in the context 
of disease) 8
Bone marrow transplantation 2       
Thoracic radiotherapy and chemotherapy 2
Systemic lupus erythematosus 1       
Beh et’ s disease 1       
Amiodarone 1       
Mycoplasmal infection 1       
Rapidly progressive BOOP 6
Idiopathic 4       
Systemic lupus erythematosus 1
Rheumatoid arthritis 1 
Excluded from BOOP: 36
Inadequate specimen 6
Interstitial pneumonia/fibrosis other than BOOP 16
Infective bronchiolitis/pneumonia 4
No bronchiolitis obliterans and microgranuloma 3
Patch organizing pneumonia suggesting post-aspiration 
reaction or association to the space-occupying lesion 7
Number of cases
Table 2. Pathologic and clinical review of 81 cases submitted
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commonly had a cellular infiltrate in the wall composed pre-
dominantly of mononuclear cells, sometimes with neutrophils
in the lumen. In some cases, acute inflammatory cells and
fibrinous exudate were also present in or near the buds, sug-
gesting that the process was still active. The intraluminal
buds frequently had central collection of inflammatory cells,
including histiocytes, lymphocytes, and plasma cells, which
tended to cluster at the center of the buds. Away from the in-
volved lung tissue, the alveoli appeared normal or minimally
affected, with slight thickening of septa with mild inflam-
matory infiltrate and slight predominance of type II cells.
Microscopical obstructive pneumonia was noted in alveoli
distal to plugged alveolar ducts as shown by intra-alveolar
aggregates of foamy macrophages. Not a single case showed
a honeycombing fibrosis.
Of the 45 patients, 8 were found to have a clearly defined
etiolology or condition, because they were associated with
an identifiable cause (e.g. infection) or with a well-defined
context (e.g. connective tissue disease, hematologic malignan-
cies, drugs, or disorders previously reported to cause BOOP):
2 cases with acute leukemia treated with bone marrow trans-
plantation and chemotherapy, 2 cases with thymic tumor
treated with thoracic radiotherapy and chemotherapy, and
one each with systemic lupus erythematosus (SLE), Beh et’ s
disease, amiodarone medication, and Mycoplasma pneumoniae
infection. These cases were classified as secondary BOOP. 
We identified six patients with a clinical course compati-
ble with rapidly progressive BOOP, because they presented
with severe respiratory failure requiring mechanical ventila-
tion or causing death despite aggressive supportive care. Two
patients were associated with SLE and rheumatoid arthritis,
respectively. In four patients the lung biopsy specimen showed
alveolar septal inflammation and mild collagenous fibrosis as
well as typical organizing pneumonia (Fig. 2). The rest re-
Fig. 1. Typical pathologic feature of BOOP. Section shows intra-
luminal fibrous buds branching in respiratory bronchioles and
alveolar ducts. Characteristic atelectatic change around patchy
lesion is perceptible (arrows) and the surrounding lung architec-
ture is well preserved. Central collection of mononuclear inflam-
matory cells is noted within buds (H&E,×40). 
Fig. 2. Idiopathic BOOP with rapidly progressive course. (A) Intraalveolar fibrous buds (arrowheads) and interalveolar septa affected with
inflammation and some collagenous fibrosis. (B) High magnification of intraalveolar buds of loose fibrous tissue and inflamed septa (arrows)
with slight fibrosis (H&E, A:×100, B:×200).
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vealed more marked septal and intraalveolar cellularity and
organizing fibrin with a BOOP pattern (Fig. 3). All six cases
showed nodularity of lesion as usually present in typical BOOP
but no histologic evidence of chronic interstitial inflamma-
tory process in the portion of the lung without involvement.
The remaining cases were classified as idiopathic BOOP not
of rapidly progressive form (Table 2).
In the final analysis, 45 patients were identified as histo-
pathologically confirmed BOOP: 31 cases as idiopathic, 8
cases as secondary, and 6 cases as rapidly progressive form.
The mean age was 50.6±11.4 yr (mean±standard devia-
tion) in idiopathic BOOP, 33.8±17.3 yr in secondary BOOP,
and 50.5±16.5 yr in rapidly progressive BOOP. The male
gender accounted for 19 of 31 cases (61.3%) in idiopathic
BOOP, 5 of 8 (62.5%) in secondary BOOP, and 4 of 6 (66.7%)
in rapidly progressive BOOP. Current or ex-smoker with
identifiable history accounted for 11 of 24 cases (46%) in
idiopathic BOOP, 2 of 6 (33.3%) in secondary BOOP, and
2 of 4 (50%) in rapidly progressive BOOP (Table 1).
Clinical manifestations
The two most common presenting symptoms were cough
and dyspnea. Cough was presented in 25 cases (80.7%) of
idiopathic BOOP, 3 cases (37.5%) of secondary BOOP, and
1 case (16.7%) of rapidly progressive BOOP. Dyspnea was
manifested in 20 cases (64.5%) of idiopathic BOOP, 3 cases
(37.5%) of secondary BOOP, and all cases of rapidly progres-
sive BOOP. Fever was present in 6 cases (19.4%) and flu-like
illness in 5 cases (16.1%) in idiopathic BOOP. The most fre-
quent physical finding was crackles, noted in 17 cases (54.8%)
of idiopathic BOOP, 3 cases (37.5%) of secondary BOOP,
and 5 cases (83.3%) of rapidly progressive BOOP (Table 1). 
The radiological findings were classified into 3 categories:
bilateral multifocal alveolar consolidations, diffuse infiltrative
lung diseases, and unifocal consolidation or mass-like lesion
(3). In idiopathic BOOP (n=31), bilateral multifocal alveo-
lar consolidations were observed in 14 cases (45.2%), diffuse
infiltrative lung diseases in 10 cases (32.3%), and unifocal
consolidation or mass-like lesion in 9 cases (29.0%). Diffuse
infiltrative lung disease was observed in 57.1% of secondary
BOOP, and in 40% of rapidly progressive BOOP (Table 3).
Respiratory physiologic parameters
Arterial blood PaO2levels on room air breathing at the time
of presentation were 76.1±13.7 mmHg (n=21) in idiopath-
ic BOOP, 74.5±17.4 mmHg (n=6) in secondary BOOP,
and 60.9±10.9 mmHg (n=4) in rapidly progressive BOOP.
Arterial hypoxemia (PaO2<80 mmHg) was recorded in 12
Bilateral multifocal 
alveolar consolidations 14 (45.2%) 3 (42.9%) 2 (40%)
Diffuse infiltrative lung 
diseases 10 (32.3%) 4 (57.1%) 2 (40%)
Unifocal consolidation or 
mass-like lesion 9 (29.0%) 0 1 (20%)
Idiopathic 
(n=31)
Secondary 
(n=7)
Rapid 
(n=5)
Table 3. Chest radiological findings
Fig. 3. Idiopathic BOOP with rapidly progressive course. (A) Intraalveolar buds of young fibromyxoid tissue (arrows) accompanied by
septa showing increased cellularity and fibrosis. (B) High magnification of intraalveolar buds associated with increased exudate, orga-
nizing (arrowheads) and cellular septa (arrows) (H&E, A:×100, B:×200).
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of 21 cases (57.1%) in idiopathic BOOP, in 4 of 6 (66.7%)
in secondary BOOP, and in 4 of 4 (100%) in rapidly progres-
sive BOOP (Table 4).
Pulmonary spirometry revealed decreased forced vital capaci-
ty (FVC) and forced expiratory volume in 1 sec (FEV1). FVC
was 71.1±21.1% of predicted value (n= 23) in idiopathic
BOOP, and 57.2±26.0 % of predicted value (n=5) in sec-
ondary BOOP. FEV1 was 72.5±20.8% of predicted value
(n=23) in idiopathic BOOP, and 62.4±32.7% of predicted
value (n=5) in secondary BOOP. Decreased FVC (<80% of
predicted value) was observed in 14 of 23 cases (60.9%) in
idiopathic BOOP, and in 4 of 5 (80.0%) in secondary BOOP.
Decreased FEV1 (<80% of predicted value) was observed in
13 of 23 cases (56.5%) in idiopathic BOOP, and in 4 of 5
(80.0%) in secondary BOOP. Obstructive pattern (FEV1/
FVC <0.70) was present in 1 of 23 cases (4.3%) in idiopathic
BOOP, and in 1 of 5 (20%) in secondary BOOP. Diffusing
capacity of the lung (DLCO) was 67.2±19.0% of predicted
value (n=16) in idiopathic BOOP, and 47.2±25.8% of
predicted value (n=4) in secondary BOOP. Decreased DLCO
(<80% of predicted value) was observed in 15 of 17 cases
(88.2%) in idiopathic BOOP, and in 4 of 4 (100% ) in secon-
dary BOOP. Specific diffusing capacity, DLCO/VA, was lower
than 80% of the predicted value in 4 of 15 cases (26.7%) in
idiopathic BOOP, and in 1 of 3 (33.3%) in secondary BOOP
(Table 4). 
Bronchoalveolar lavage
Bronchoalveolar lavage (BAL) by bronchoscopy was per-
formed in 12 cases of idiopathic BOOP, and 2 of secondary
BOOP. The differential counts of the BAL fluid were avail-
able in 11 idiopathic BOOP cases. An increase of lympho-
cytes (>25%) was observed in 7 cases (63.6%). An increase of
neutrophils (>5%) and that of eosinophils (>2%) were ob-
served in 6 cases (54.5%) and in 5 (45.5%), respectively. An
increase of both lymphocytes and neutrophils was observed
in 5 cases (45.5%), and that of both lymphocytes and eosino-
phils was observed in 4 (36.4%). An increase of lymphocytes,
neutrophils, and eosinophils was observed in 3 cases (27.3%).
Laboratory parameters
Peripheral blood leukocytosis (WBC >10,000/ L) was man-
ifested in 10 of 30 cases (33.3%) in idiopathic BOOP, in 3
of 6 (50.0%) in secondary BOOP, and in 1 of 5 (20.0%) in
rapidly progressive BOOP. Decreased serum albumin level
(<3.5 g/dL) was observed in 12 of 28 cases (42.9%) in idio-
pathic BOOP, in 2 of 5 (40%) in secondary BOOP, and in 3
of 4 (75%) in rapidly progressive BOOP. Serum antinuclear
antibody test was positive in 3 of 29 cases (10.3%) in idio-
pathic BOOP, in 1 of 8 (12.5%) in secondary BOOP, and in
1 of 6 (16.7%) in rapidly progressive BOOP. Serum rheuma-
toid factor was present in 1 of 29 cases (3.4%) in idiopathic
BOOP, and in 1 of 6 (16.7%) in rapidly progressive BOOP
(Table 4).
Treatment and clinical outcome
Twenty patients with idiopathic BOOP received predni-
solone and other corticosteroid treatment. Eighteen of them
were evaluable for the outcome: 11 cases (61.1%) showed
complete recovery of symptoms and radiological resolution,
5 cases (27.8%) showed partial recovery, and one each case
(5.6%) showed no change and aggravation, respectively.
Among 11 idiopathic BOOP patients without corticosteroid
treatment, 6 cases showed complete recovery, 1 case showed
partial recovery, and the remaining 4 patients were not assess-
able for the clinical outcome. Among 31 idiopathic BOOP
patients, 23 (74.2%) improved: 17 (54.8%) recovered com-
pletely and 6 (19.4%) recovered partially (Table 5). There was
no mortality. 
Complete recovery 11 6 1 2 - -
Partial recovery 5 1 1 - - -
No change 1 - - - - -
Aggravation 1 - - - 3 3
Unable to evaluate 2 4 2 2
Total 20 11 4 4 3 3
Idiopathic
Corticosteroid
Secondary
Corticosteroid
Rapid
Corticosteroid
Yes      No Yes      No Yes      No
Table 5. Treatment and clinical outcome 
PaO2 (mmHg) 76.1±13.7* 74.5±17.4 60.9±10.9 
(n=21) (n=6) (n =4)
PaO2 <80 mmHg 12/21 (57.1%) 4/6 (66.7%) 4/4 (100%)
FVC 71.1±21.1
� 57.2± 26.0 
(n=23) (n=5)
FVC <80% of 
predicted 14/23 (60.9%) 4/5 (80.0%)
FEV1 72.5±20.8 62.4±32.7 
(n=23) (n=5)
FEV1 <80% of 
predicted 13/23 (56.5%) 4/5 (80.0%)
DLCO 67.2±19.0 47.2±25.8 
(n=16) (n=4)
WBC>10,000/ L 10/30 (33.3%) 3/6 (50.0%) 1/5 (20.0%)
WBC<4,000/ L 2/30 (6.7%) 1/6 (16.7%) 0
ESR>60 mm/hr 1/11 (9.1%) 1/5 (20%) 1/4 (25%)
Positive antinuclear 
antibody 3/29 (10.3%) 1/8 (12.5%) 1/6 (16.7%)
Positive rheumatoid 
factor 1/29 (3.4%) 0/8 (0%) 1/6 (16.7%)
Idiopathic Secondary Rapid
Table 4. Respiratory physiologic and laboratory parameters
at diagnosis
*Values are expressed as mean±standard deviation, 
� Values are ex-
pressed as percentage of predicted.184 J. Chang, J. Han, D.W. Kim, et al.
Four out of eight patients with secondary BOOP received
prednisolone (Table 5). One patient had died 12 months after
the diagnosis due to the lung involvement of thymic carci-
noma. 
All six patients with rapidly progressive BOOP died within
two months after the diagnosis. The mean duration of survival
was 4±2.5 weeks (n=5). Three patients were not treated by
corticosteroid or antiinflammatory agents. Three patients
received intravenous administration of methylprednisolone
1,000 mg/day or at larger doses, and two patients received
intravenous administration of cyclophosphamide 1,000 mg/
day in addition to the corticosteroid therapy (Table 5) .
DISCUSSION
For the clinical classification of BOOP, clinicians must have
specific information regarding the patients’ clinical setting
or underlying illnesses. In this study we were able to obtain
further clinical information by formulating standard data
sheet with complete list of conditions and drugs previously
reported to be the cause or to be associated with BOOP. As a
result, 10 cases of BOOP (including 2 cases of rapidly pro-
gressive BOOP) were found to be associated with these con-
ditions or drugs. Although some of them might have no direct
relation between the occurrence of BOOP and the underly-
ing conditions, it is very important to identify any possibly
related clinical settings before making a diagnosis of idiopath-
ic BOOP, because it has been known that the cases associ-
ated with another chronic disease process, especially collagen
vascular diseases and autoimmune diseases, had poor outcome,
compared with idiopathic cases despite identical histologic
findings (1, 4, 6, 18).
The open lung biopsy has been preferred for a definitive
diagnosis, but video-guided thoracoscopy can also provide
sufficient tissue specimen to establish a diagnosis. In selected
situations, a transbronchial biopsy examination may be use-
ful if both bronchiolar and alveolar elements are present in
the tissue specimen accompanied with typical clinical and
radiological findings (16, 20). 
There were limitations in the interpretation of our clinical
data, because the cases were collected retrospectively from
many hospitals. Even though we used a standardized data
sheet, some data were missing. Protocols for clinical therapy
and follow-up were not uniform. The incidence for each clini-
cal finding was generally somewhat lower than those of the
previous reports, most likely because of the retrospective na-
ture of the present analysis and incomplete follow-up. Even
with these limitations, this is the first study in Korea with
critical review of biopsied lung tissues applying uniform cri-
teria, and identification of cases of so-called rapidly progres-
sive BOOP. We would like to recommend that a standard-
ized data sheet be applied in future prospective study to avoid
loss of important clinical history and findings. 
In Korea there was one retrospective clinical study of BOOP
in a smaller group of Korean patients comprised of 23 cases
including 10 outside cases previously reported in Korean
literatures (21). Eighteen of the 23 cases (78%) were classi-
fied as idiopathic BOOP and the other five were revealed to
have associated connective tissue diseases. The authors ob-
served female predominance with a male-to-female ratio of
1:2 in idiopathic BOOP, which had not been reported in other
reports. They speculated that this difference might be ex-
plained in terms of either ethnic characteristics of Korea or
a selection bias from a small number of cases. The present
study did not show a gender difference in Korean BOOP
patients including all 3 categories, that is, idiopathic, secon-
dary, and rapidly progressive forms. 
A few case reports have been published on an accelerated
or rapidly progressive form of BOOP in a small percentage
of patients (12, 13). In a recent review of 10 such cases, all
but one were associated with various illnesses, such as rheuma-
toid arthritis, asthma, dermatomyositis, cancer, hypothy-
roidism, and chronic obstructive pulmonary disease (14). All
10 patients underwent an open lung biopsy that revealed
their predominant histopathology to be BOOP. In addition,
alveolar septal inflammation/fibrosis and honeycombing were
common features at autopsy. The authors speculated that
BOOP could be a precursor of alveolar septal inflammation
and honeycomb lung and thus might represent an early phase
of the temporal spectrum of interstitial lung disease. Yousem
et al. (15) also noted that cases of idiopathic BOOP nonrespon-
sive to corticosteroid were accompanied by scarring and re-
modeling of the background parenchyma in 89% of cases,
in contrast to 10% of those with good prognosis. There were
no honeycombing changes in their cases and they suggested
that the background fibrosis might have resulted from aggres-
sive nature of BOOP or pre-existing lung damage caused by
a chronic interstitial pneumonia with superimposed BOOP
reaction. Our analysis of cases with progressive BOOP does
not allow for definitive conclusions as to whether the inter-
alveolar septal fibrosis is a part of BOOP that involves the
alveolar interstitium or just secondary reaction to the preexist-
ing chronic interstitial inflammation. This is partly because
none of six cases had follow-up lung biopsies or postmortem
examination, so that we were not able to definitely exclude
the possibility of preexisting chronic lung disease. In this re-
gard, intraluminal organization is sometimes observed with-
in the airspace in the transbronchial lung biopsy specimens
obtained from patients with the clinical characteristics of
idiopathic pulmonary fibrosis (IPF) raising the possibility of
organizing pneumonia. The confusion between BOOP and
fibrosing interstitial pneumonia/usual interstitial pneumonia
(UIP) can be traced to the interpretation of extensive intra-
airway organization as  “interstitial fibrosis”(16, 17). The
differential diagnosis is important, however, because patients
with BOOP have a favorable prognosis and response to ther-
apy, compared with those with UIP (22).Bronchiolitis Obliterans Organizing Pneumonia (BOOP) 185
The histologic differential diagnosis of BOOP can be divid-
ed into 2 broad groups (16). The first group is comprised of
lesions that may show a BOOP pattern. Since BOOP are
common reparative reactions in the lung, there are numer-
ous lesions that may show a BOOP pattern as part of their
histologic features. Indeed a major issue for pathologists in
the diagnosis of organizing pneumonia (OP) is the exclusion
of infection, because many organizing infections may show
a pattern similar to that of BOOP. Thus negative special stains
for microorganisms and biopsy cultures should be confirmed
prior to making the diagnosis of COP. The term COP was
suggested in order to avoid confusion with post-infective
organizing pneumonia (2). The second group was established
in part because of the clinical presentation and because they
represent idiopathic fibrosing interstitial pneumonias. This
group includes idiopathic organizing DAD/acute interstitial
pneumonia (AIP) and IPF. Organizing DAD shows some
overlap with BOOP histologically, although the changes in
the former tend to be more extensive, uniform, and conflu-
ent, and hyaline membranes are often present in the former.
There are some cases of idiopathic organizing DAD that show
both clinical and histologic overlap with BOOP, and the dis-
tinction between the two may be somewhat arbitrary (16, 17). 
Nagata et al. (23) presumed that IPF with OP represents
an incompletely resolved course of BOOP that is accompa-
nied with fibrotic changes. However, patients with IPF and
OP can not be classified as BOOP, because the honeycombing
appearance on their chest radiography or CT scans is report-
edly never seen in BOOP patients (1) and moreover, the pres-
ence of honeycombing as part of the interstitial pneumonia
(and not an incidental finding) serves as evidence against the
diagnosis of BOOP (16, 17). More studies are needed to define
the relationship between BOOP presenting as an infiltrative
pulmonary disease and UIP.
The histologic features of BOOP are frequently encounted
in cases of HP and organizing CEP. A few eosinophils are oc-
casionally seen in lesions of BOOP, but numerous eosinophils
raise the possibility of organizing CEP or an organizing aller-
gic reaction, such as a drug reaction. Some cases appear to rep-
resent true hybrid cases of either BOOP and CEP or BOOP
and HP. Likewise, the presence of more than a rare or isolat-
ed granuloma should lead to an exclusion of granulomatous
infection and, more commonly, HP (16, 17). 
Solitary focal pneumonia has been suggested as the third
imaging pattern of BOOP (10) and such cases have been re-
ported (24, 25). Some patients present with a subacute process
identical to typical BOOP, whereas others are asymptomatic
and the solitary pulmonary opacity is often located in the up-
per lobes. Given the propensity of aspiration to affect upper
lobe particularly apicoposterior segment in supine postion
(26), difficulties arise as to the pathologic differentiation be-
tween focal solitary BOOP and just localized OP following
aspiration, despite great efforts to detect foreign bodies or
extrinsic lipid. We suspect that some cases probably corre-
spond to unresolved pneumonia and indeed the possibility
has been suggested that BOOP might have resulted from
organization of any other type of infectious pneumonia (18,
27).
In summary we performed a critical and comprehensive
review of 45 cases of biopsy-proven BOOP and were able to
ascertain cases of rapidly progressive BOOP histologically
characterized with interalveolar septal inflammation and fibro-
sis. However we could not identify definite risk factors for
an unfavorable outcome in BOOP, for which larger prospec-
tive studies are warranted in the future. 
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